Society of Family Planning

Last updated
Society of Family Planning
AbbreviationSFP
Formation2005
President
Angela Dempsey
President-Elect
Sadia Haider
Website societyfp.org

The Society of Family Planning (SFP) is an international non-profit [1] professional organization established in 2005 specializing in "abortion and contraception science" [2] [3] composed of physicians, nurses, sociologists, public health practitioners and trainees in these fields. [4] The majority of member physicians include specialists of obstetrics and gynecology, family medicine, and adolescent medicine. [4]

Contents

The organization sponsors the Society of Family Planning Research Fund that provides grants for research in abortion and contraception. [4] This funding source was established in 2011. The Society of Family Planning supports the Fellowship in Complex Family Planning, previously known as the Fellowship in Family Planning. The fellowship is certified by the American Board of Obstetrics and Gynecology (ABOG), member of the American Board of Medical Specialties, as a subspecialty of Obstetrics and Gynecology. [5]

Background

The Society of Family Planning was created in 2005 by 18 founding members and 33 charter members, initially focusing on grant support for rigorous family planning research. [4] [6] Membership has expanded to almost 800 members as of 2017. [4] As of 2020, the scope of the organization includes education based on clinical guidelines, research and grants, and advocacy through clinical guidelines and research. [4] [7] [8] The organization holds an annual meeting called the North American Forum on Family Planning (the Forum). [9]

There are three categories of membership: Fellow, Junior Fellow, and Affiliate Fellow. [10] In order to apply for membership, a potential applicant must be referred by a current member. [11] Members connect to the Society and collaborate with each other through Society of Family Planning Connect. [12]

Contraception published by Elsevier is the official SFP medical journal. [13] As of 2019, the journal has an Impact Factor of 2.819.

Governance and committees

The Society of Family Planning is managed by staff members including an Executive Director and an elected Board of Directors. [2] The organization is also made up of Committees, Subcommittees and Working Groups including the Executive, Governance, and Finance Committees; Complex Family Planning Council; Annual Meeting, Clinical Affairs and Research Affairs Subcommittees; Abortion Clinical Research Network Working Group; and Diversity, Equity and Inclusion Working Group. [2]

Research and grants

The Society of Family Planning was originally created to provide grant support for family planning research. While the Society's scope has expanded, it has continued to provide significant research support, funding over $2.6 million dollars in grants in 2019. [14] After an analysis of the impact of a decade of grantmaking, [15] [8] the Society of Family Planning Research Fund transitioned to funding targeted grant opportunities, published in the spring and awarded in the fall. SFP also supports the Abortion Clinical Research Network, a multi-site research network including independent clinics, Planned Parenthood affiliates, academic practices, patients, and researchers. [16] [8]

Fellowship in Complex Family Planning

The Fellowship in Complex Family Planning (CFP) is accredited by the Accreditation Council for Graduate Medical Education as a two-year fellowship after completing specialty training in obstetrics and gynecology. [17] [5] [18] The fellowship focuses on further clinical training and research on complex abortion and contraception. SFP's Complex Family Planning Council partners with ABOG to provide programmatic oversight of the fellowship. [19] Many academic institutions offer this fellowship training including Columbia University; [20] Johns Hopkins University; [21] University of California, Davis; [22] University of Michigan; [23] University of Southern California; [24] and Yale University. [25] [18]

Legislative advocacy

Together with other medical and reproductive health organizations, the Society of Family Planning filed amicus briefs in Sebelius v. Hobby Lobby, [26] [27] later Burwell v. Hobby Lobby, [28] to support increased access to the full range of contraceptive methods approved by the US Food and Drug Administration. In her dissenting opinion, Justice Ruth Bader Ginsburg highlighted the importance of contraception to women in whom pregnancy may pose life-threatening risk and non-contraceptive benefits including cancer prevention and treatment of menstrual disorders and pelvic pain. [28]

The American Civil Liberties Union filed Chelius v. Wright on behalf of Dr. Graham Chelius, the Society of Family Planning, and other organizations against the restricted access to medical abortion. [29] [30]

The Society of Family Planning joined other medical organizations in the amicus brief ACOG v. US Food and Drug Administration against the in-person dispensing requirement of mifepristone in medical abortion. [31] [32] [33]

Collaborations

The American College of Obstetricians and Gynecologists (ACOG) and Society of Family Planning jointly developed clinical guidance on medical abortion up to 70 days' gestation. [34] SFP endorsed ACOG's Practice Guideline on second-trimester abortion. [35]

After a workshop entitled "Reproductive Services for Women at High Risk for Maternal Mortality", ACOG, SFP, Society for Maternal-Fetal Medicine (SMFM), and the Fellowship in Family Planning, now known as the Fellowship in Complex Family Planning, [17] issued an executive summary [36] and consensus statement [37] regarding assessment, counseling, and training on reproductive health services for women at high risk for maternal morbidity and mortality. [38] [39] To promote development of evidence-based guidelines for reproductive health services associated with high-risk pregnancies, SFP and SMFM are partnering to offer the SMFM and SFP Bridge Builder Award for research funding. [40] SMFM refers to SFP guidance on contraceptive provision when there is restricted healthcare access during the COVID-19 pandemic. [41] [42]

The Society of Family Planning released a statement to preserve timely access to abortion services during the COVID-19 pandemic, in collaboration with ACOG, ABOG, American Association of Gynecologic Laparoscopists, American Gynecological and Obstetrical Society, American Society for Reproductive Medicine, the Society for Academic Specialists in General Obstetrics and Gynecology, and SMFM. [43]

Related Research Articles

Abortion is the termination of a pregnancy by removal or expulsion of an embryo or fetus. An abortion that occurs without intervention is known as a miscarriage or "spontaneous abortion"; these occur in approximately 30% to 40% of pregnancies. When deliberate steps are taken to end a pregnancy, it is called an induced abortion, or less frequently "induced miscarriage". The unmodified word abortion generally refers to an induced abortion. The reasons why women have abortions are diverse and vary across the world. Reasons include maternal health, an inability to afford a child, domestic violence, lack of support, feeling they are too young, wishing to complete education or advance a career, and not being able or willing to raise a child conceived as a result of rape or incest.

Dilationand curettage (D&C) refers to the dilation (widening/opening) of the cervix and surgical removal of part of the lining of the uterus and/or contents of the uterus by scraping and scooping (curettage). It is a gynecologic procedure used for diagnostic and therapeutic purposes, and is the most commonly used method for first-trimester miscarriage or abortion.

<span class="mw-page-title-main">Obstetrics and gynaecology</span> Medical specialty encompassing two subspecialties

Obstetrics and Gynaecology is the medical specialty that encompasses the two subspecialties of obstetrics and gynecology.

<span class="mw-page-title-main">Maternal death</span> Aspect of human reproduction and medicine

Maternal death or maternal mortality is defined in slightly different ways by several different health organizations. The World Health Organization (WHO) defines maternal death as the death of a pregnant mother due to complications related to pregnancy, underlying conditions worsened by the pregnancy or management of these conditions. This can occur either while they are pregnant or within six weeks of resolution of the pregnancy. The CDC definition of pregnancy-related deaths extends the period of consideration to include one year from the resolution of the pregnancy. Pregnancy associated death, as defined by the American College of Obstetricians and Gynecologists (ACOG), are all deaths occurring within one year of a pregnancy resolution. Identification of pregnancy associated deaths is important for deciding whether or not the pregnancy was a direct or indirect contributing cause of the death.

Late termination of pregnancy, also referred to as late-term abortion, describes the termination of pregnancy by induced abortion during a late stage of gestation. In this context, late is not precisely defined, and different medical publications use varying gestational age thresholds. As of 2015 in the United States, more than 90% of abortions occur before the 13th week, 1.3% of abortions in the United States took place after the 21st week, and less than 1% occur after 24 weeks.

Dilation and evacuation (D&E) is the dilation of the cervix and surgical evacuation of the uterus after the first trimester of pregnancy. It is a method of abortion as well as a common procedure used after miscarriage to remove all pregnancy tissue.

<span class="mw-page-title-main">Self-induced abortion</span> Abortion performed by a pregnant person themselves outside the recognized medical system

A self-induced abortion is an abortion performed by the pregnant woman herself, or with the help of other, non-medical assistance. Although the term includes abortions induced outside of a clinical setting with legal, sometimes over-the-counter medication, it also refers to efforts to terminate a pregnancy through alternative, potentially more dangerous methods. Such practices may present a threat to the health of women.

<span class="mw-page-title-main">Maternal–fetal medicine</span> Branch of medicine

Maternal–fetal medicine (MFM), also known as perinatology, is a branch of medicine that focuses on managing health concerns of the mother and fetus prior to, during, and shortly after pregnancy.

Reproductive endocrinology and infertility (REI) is a surgical subspecialty of obstetrics and gynecology that trains physicians in reproductive medicine addressing hormonal functioning as it pertains to reproduction as well as the issue of infertility. While most REI specialists primarily focus on the treatment of infertility, reproductive endocrinologists are trained to also test and treat hormonal dysfunctions in females and males outside infertility. Reproductive endocrinologists have specialty training (residency) in obstetrics and gynecology (ob-gyn) before they undergo sub-specialty training (fellowship) in REI.

<span class="mw-page-title-main">Osmotic dilator</span> Medical device to dilate the uterine cervix

Osmotic dilators are medical implements used to dilate the uterine cervix by swelling as they absorb fluid from surrounding tissue. They may be composed of natural or synthetic materials. A laminaria stick or tent is a thin rod made of the stems of dried Laminaria, a genus of kelp. Laminaria sticks can be generated from Laminaria japonica and Laminaria digitata. Synthetic osmotic dilators are commonly referred to by their brand names, such as Dilapan. Dilapan-S are composed of polyacrylonitrile, a plastic polymer. The hygroscopic nature of the polymer causes the dilator to absorb fluid and expand.

Long-acting reversible contraceptives (LARC) are methods of birth control that provide effective contraception for an extended period without requiring user action. They include injections, intrauterine devices (IUDs), and subdermal contraceptive implants. They are the most effective reversible methods of contraception because their efficacy is not reliant on patient compliance. The typical use failure rates of IUDs and implants, less than 1% per year, are about the same as perfect use failure rates.

<span class="mw-page-title-main">Birth control</span> Method of preventing human pregnancy

Birth control, also known as contraception, anticonception, and fertility control, is the use of methods or devices to prevent unwanted pregnancy. Birth control has been used since ancient times, but effective and safe methods of birth control only became available in the 20th century. Planning, making available, and using human birth control is called family planning. Some cultures limit or discourage access to birth control because they consider it to be morally, religiously, or politically undesirable.

Unintended pregnancies are pregnancies that are mistimed, unplanned or unwanted at the time of conception.

<span class="mw-page-title-main">Intrauterine device</span> Form of birth control involving a device placed in the uterus

An intrauterine device (IUD), also known as intrauterine contraceptive device or coil, is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). One study found that female family planning providers choose LARC methods more often (41.7%) than the general public (12.1%). Among birth control methods, IUDs, along with other contraceptive implants, result in the greatest satisfaction among users.

<span class="mw-page-title-main">American College of Obstetricians and Gynecologists</span> US professional association

The American College of Obstetricians and Gynecologists (ACOG) is a professional association of physicians specializing in obstetrics and gynecology in the United States. Several Latin American countries are also represented within Districts of the organization. It is a 501(c)(3) organization with a membership of more than 60,000 obstetrician-gynecologists and women's health care professionals. It was founded in 1951.

<span class="mw-page-title-main">Ipas (organization)</span>

Ipas is an international, non-governmental organization that seeks to increase access to safe abortions and contraception. To this end the organization informs women how to obtain safe and legal abortions and trains relevant partners in Africa, Asia, and Latin America on how to provide and advocate for these.

Reproductive coercion is a collection of behaviors that interfere with decision-making related to reproductive health. These behaviors are meant to maintain power and control related to reproductive health by a current, former, or hopeful intimate or romantic partner, but they can also be perpetrated by parents or in-laws. Coercive behaviors infringe on individuals' reproductive rights and reduce their reproductive autonomy.

A medical abortion, also known as medication abortion, occurs when drugs (medication) are used to bring about an abortion. Medical abortions are an alternative to surgical abortions such as vacuum aspiration or dilation and curettage. Medical abortions are more common than surgical abortions in most places, including Europe, India, China, and the United States.

<span class="mw-page-title-main">Combined hormonal contraception</span> Form of hormonal contraception combining both an estrogen and a progestogen

Combined hormonal contraception (CHC), or combined birth control, is a form of hormonal contraception which combines both an estrogen and a progestogen in varying formulations.

The American Board of Obstetrics and Gynecology is a non-profit organization that provides board certification for practicing obstetricians and gynecologists in the United States and Canada. It was founded in 1927, incorporated in 1930, and is based in Dallas, Texas. It is one of 24 medical boards recognized by the American Board of Medical Specialties. ABOG's mission is to define the standards, certify obstetricians and gynecologists, and facilitate continuous learning to advance knowledge, practice, and professionalism in women's health.

References

  1. ↑ "Bloomberg company profile: SFP". Bloomberg News . Retrieved 2020-08-25.
  2. 1 2 3 "Society of Family Planning About Us" . Retrieved 2020-08-24.
  3. ↑ Koerth, Maggie (2022-10-30). "Overturning Roe Has Meant At Least 10,000 Fewer Legal Abortions". FiveThirtyEight. Retrieved 2022-11-06.
  4. 1 2 3 4 5 6 "Society of Family Planning Strategic Plan" . Retrieved 2020-08-24.
  5. 1 2 "ABOG OB/Gyn subspecialties" . Retrieved 2020-08-25.
  6. ↑ Darney, Philip; Creinin, Mitchell D.; Nichols, Mark; Gilliam, Melissa; Westhoff, Carolyn L. (2015-01-10). "Tenth anniversary of the Society of Family Planning". Contraception. 92 (4): 279–281. doi: 10.1016/j.contraception.2015.08.005 . ISSN   0010-7824. PMID   26272310.
  7. ↑ Espey, Eve; Dennis, Amanda; Landy, Uta (January 2019). "The importance of access to comprehensive reproductive health care, including abortion: a statement from women's health professional organizations". American Journal of Obstetrics and Gynecology. 220 (1): 67–70. doi:10.1016/j.ajog.2018.09.008. ISSN   0002-9378. PMID   30267653. S2CID   52893193.
  8. 1 2 3 Dennis, Amanda; Manski, Ruth; O'Donnell, Jenny (April 2020). "Assessing research impact: A framework and an evaluation of the Society of Family Planning Research Fund's grantmaking (2007–2017)". Contraception. 101 (4): 213–219. doi: 10.1016/j.contraception.2019.11.007 . ISSN   0010-7824. PMID   31857077.
  9. ↑ "North American Forum on Family Planning" . Retrieved 2020-08-24.
  10. ↑ "Society of Family Planning membership" . Retrieved 2020-08-24.
  11. ↑ "Society of Family Planning application for membership" . Retrieved 2020-08-24.
  12. ↑ "Society of Family Planning Connect" . Retrieved 2020-08-24.
  13. ↑ "Contraception journal" . Retrieved 2020-08-24.
  14. ↑ "2019 Annual Report" (PDF). Society of Family Planning. Retrieved 24 August 2020.
  15. ↑ Bruce, L 2012. "Filling a Funding Gap: An Impact Evaluation of the Society of Family Planning," MPH Thesis, Drexel University, Philadelphia.
  16. ↑ "Abortion Clinical Research Network". Society of Family Planning. Retrieved 24 August 2020.
  17. 1 2 "Ob/Gyn Board Seeks New Family Planning Subspecialty". 22 June 2018. Retrieved 2020-08-24.
  18. 1 2 "Fellowship in Complex Family Planning" . Retrieved 2020-08-24.
  19. ↑ "Society of Family Planning Committees, Subcommittees and Working Groups" . Retrieved 2020-08-24.
  20. ↑ "Columbia University CFP Fellowship". 6 June 2017. Retrieved 2020-08-24.
  21. ↑ "Johns Hopkins University CFP Fellowship" . Retrieved 2020-08-24.
  22. ↑ "UC Davis CFP Fellowship" . Retrieved 2020-08-24.
  23. ↑ "University of Michigan CFP Fellowship" . Retrieved 2020-08-24.
  24. ↑ "USC CFP Fellowship" . Retrieved 2020-08-24.
  25. ↑ "Yale University CFP Fellowship" . Retrieved 2020-08-24.
  26. ↑ "Sebelius v. Hobby Lobby Nos. 13-354 and 13-356" (PDF). 2014-01-28. Retrieved 2020-08-25.
  27. ↑ "Sebelius v. Hobby Lobby No. 13-354" (PDF). 2013-10-21. Retrieved 2020-08-25.
  28. 1 2 "Burwell v. Hobby Lobby" (PDF). October 2013. Retrieved 2020-08-25.
  29. ↑ "ACLU Press Release: Chelius v Wright" . Retrieved 2020-08-25.
  30. ↑ "Abortion access -- we have the answer". Medium. Retrieved 2020-08-25.
  31. ↑ "SFP News and Updates". 5 June 2020. Retrieved 2020-08-25.
  32. ↑ "ACOG News Release: ACOG v. FDA" . Retrieved 2020-08-25.
  33. ↑ McCammon, Sarah (27 May 2020). "NPR: ACOG v. FDA". NPR. Retrieved 2020-08-25.
  34. ↑ Practice Bulletins—Gynecology, the Society of Family Planning (2020). "Medication Abortion up to 70 Days of Gestation". Contraception. 102 (4): 225–236. doi: 10.1016/j.contraception.2020.08.004 . ISSN   0010-7824. PMID   32807380.
  35. ↑ "ACOG Practice Bulletin No. 135: Second-trimester abortion". Obstetrics and Gynecology. 121 (6): 1394–1406. June 2013. doi:10.1097/01.AOG.0000431056.79334.cc. ISSN   1873-233X. PMID   23812485. S2CID   205384119.
  36. ↑ Society for Maternal-Fetal Medicine (SMFM) (2019). "Executive summary: Reproductive Services for Women at High Risk for Maternal Mortality Workshop, February 11–12, 2019, Las Vegas, Nevada". American Journal of Obstetrics and Gynecology. 221 (4): B2–B5. doi: 10.1016/j.ajog.2019.06.032 . ISSN   0002-9378. PMID   31226292.
  37. ↑ Blackwell, Sean; Louis, Judette M.; Norton, Mary E.; Lappen, Justin R.; Pettker, Christian M.; Kaimal, Anjali; Landy, Uta; Edelman, Alison; Teal, Stephanie; Landis, Roxanne (April 2020). "Reproductive services for women at high risk for maternal mortality: a report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Family Planning". American Journal of Obstetrics and Gynecology. 222 (4): B2–B18. doi:10.1016/j.ajog.2019.12.008. ISSN   0002-9378. PMID   32252942. S2CID   215407612.
  38. ↑ "SMFM Publications and Guidelines: Reproductive services for women at high risk for maternal mortality—a report of the workshop" . Retrieved 2020-08-25.
  39. ↑ "SMFM Publications and Guidelines: Executive Summary of Reproductive Services for Women at High Risk for Maternal Mortality" . Retrieved 2020-08-25.
  40. ↑ "SMFM and SFP Bridge Builder Awards". 24 January 2020. Retrieved 2020-08-24.
  41. ↑ "SMFM COVID-19 Partner Resources" . Retrieved 2020-08-25.
  42. ↑ "Updated interim recommendations for contraceptive provision". Society of Family Planning. 2020-05-29. doi:10.46621/uygr2287. S2CID   241531598 . Retrieved 2020-09-01.
  43. ↑ "Cochrane Fertility Regulation News And Events: COVID-19" . Retrieved 2020-08-25.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.